22nd Century Group (NYSE: XXII) is a plant biotechnology company that uses genetic engineering and plant breeding technology to decrease or increase the level of nicotine and other nicotinic alkaloids in tobacco plants. The company is also developing a prescription … Continue reading →

FTE Networks (OTC: FTNW), together with its subsidiaries, provides international and regional telecommunications and technology systems, and infrastructure services. The company specializes in the design, engineering, installation and maintenance of various forms of telecommunications infrastructure, also provides wireless solutions to … Continue reading →

Jaguar Animal Health (NASDAQ: JAGX) is an animal health company focused on the development and commercialization of first-in-class gastrointestinal products for companion and production animals, foals, and high-value horses. The company’s lead prescription drug product candidate, Canalevia™, is intended for … Continue reading →

Citius Pharmaceuticals (OTC: CTXR) is a specialty pharmaceutical company that develops and commercializes therapeutic products. The company’s product portfolio includes: Suprenza ODT, a phentermine orally disintegrating tablet used for the treatment of obesity; and Hydrocortisone-Lidocaine Cream, in phase 2 of … Continue reading →

U.S. Geothermal, Inc. (NYSE: HTM) is a profitable renewable energy company focused on the development, production and sale of electricity from geothermal energy. The company is currently operating geothermal power projects in Oregon, Nevada and Idaho, representing a total power … Continue reading →